$TKCM
TOKEN COMMUNITIES LTD.

2023 Q1 Form 10-Q Financial Statement

#000147793223001166 Filed on February 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $30.59K $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $59.64K $36.94K $32.47K
YoY Change 26.51% 13.78%
Operating Profit -$29.05K -$36.94K -$32.47K
YoY Change -38.38% 13.78%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $7.029K $0.00
YoY Change -31.32%
Pretax Income -$29.05K
YoY Change -38.38%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$27.09K -$36.94K -$32.47K
YoY Change -42.55% 13.78%
Net Earnings / Revenue -88.54%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 2.096B shares 2.096B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $412.00 $312.00 $312.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $50.00K
Other Receivables
Total Short-Term Assets $50.41K $50.31K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $836.00 $836.00
YoY Change
Total Long-Term Assets $836.00 $836.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $50.41K $50.31K
Total Long-Term Assets $836.00 $836.00
Total Assets $51.25K $51.15K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $472.5K
YoY Change
Accrued Expenses $354.5K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.495M $2.253M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.495M $2.253M
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$2.735M -$3.442M
YoY Change
Common Stock $209.6K $209.6K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.444M -$2.202M -$1.931M
YoY Change
Total Liabilities & Shareholders Equity $51.25K $51.15K
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income -$27.09K -$36.94K -$32.47K
YoY Change -42.55% 13.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Profit Loss
ProfitLoss
-160391 usd
dei Entity Shell Company
EntityShellCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0001683252
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2095872947 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2095872947 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2095872947 shares
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Entity File Number
EntityFileNumber
000-55688
dei Entity Registrant Name
EntityRegistrantName
Token Communities Ltd.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-3709511
dei Entity Address Address Line1
EntityAddressAddressLine1
4802 Lena Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 105
dei Entity Address City Or Town
EntityAddressCityOrTown
Bradenton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34211
dei City Area Code
CityAreaCode
631
dei Local Phone Number
LocalPhoneNumber
397-1111
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2095671162 shares
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
312 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
312 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
50000 usd
CY2022Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
50000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
50312 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
50312 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
836 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
836 usd
CY2022Q4 us-gaap Assets
Assets
51148 usd
CY2022Q2 us-gaap Assets
Assets
51148 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
472488 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
472488 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
354542 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
354542 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1425676 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1258676 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2252706 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2085706 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2095872947 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
209587 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
209587 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1039610 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1039610 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8977 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5603 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3441778 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3278152 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2201558 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2034558 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51148 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51148 usd
CY2022Q4 us-gaap Revenues
Revenues
0 usd
CY2021Q4 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36943 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32469 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
163626 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
160391 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
36943 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
32469 usd
us-gaap Operating Expenses
OperatingExpenses
163626 usd
us-gaap Operating Expenses
OperatingExpenses
160391 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-36943 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-32469 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-163626 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-160391 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-36943 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-32469 usd
us-gaap Profit Loss
ProfitLoss
-163626 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3345 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8750 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3374 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16491 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40288 usd
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41219 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-167000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-176882 usd
CY2022Q4 f10q0922 Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
0.00
CY2021Q4 f10q0922 Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
0.00
f10q0922 Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
0.00
f10q0922 Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
0.00
CY2022Q4 f10q0922 Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2095671162 shares
CY2021Q4 f10q0922 Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2095671162 shares
f10q0922 Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2095671162 shares
f10q0922 Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2095671162 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1753869 usd
f10q0922 Foreign Currency Translation Gain Amount
ForeignCurrencyTranslationGainAmount
-16491 usd
f10q0922 Net Income For The Period Amount
NetIncomeForThePeriodAmount
-160391 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1930750 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2034558 usd
f10q0922 Foreign Currency Translation Gain Amount
ForeignCurrencyTranslationGainAmount
-3374 usd
f10q0922 Net Income For The Period Amount
NetIncomeForThePeriodAmount
-163626 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2201558 usd
us-gaap Net Income Loss
NetIncomeLoss
163626 usd
us-gaap Net Income Loss
NetIncomeLoss
160391 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-163626 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
167000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
167000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
176882 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3374 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-16491 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
312 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
312 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
312 usd
CY2018Q1 f10q0922 Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
1 pure
f10q0922 Number Of Shares Outstanding Prior To Merger
NumberOfSharesOutstandingPriorToMerger
116466000 shares
CY2022Q4 f10q0922 Surrender Stockholder Shares
SurrenderStockholderShares
19266000 shares
CY2020Q3 f10q0922 Stock Cancelled During Period Shares Acquisitions
StockCancelledDuringPeriodSharesAcquisitions
174540600 shares
f10q0922 Foreign Currency Translationtabletextblock
ForeignCurrencyTranslationtabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Period end: GBP to USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.12</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.37</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Average period: GBP to USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.17</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.31</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q4 f10q0922 Accrued Director Fees
AccruedDirectorFees
236582 usd
CY2022Q2 f10q0922 Accrued Director Fees
AccruedDirectorFees
236582 usd
CY2019Q3 f10q0922 Stock Issued During Period Shares Acquisition
StockIssuedDuringPeriodSharesAcquisition
80000000 shares
CY2020Q2 us-gaap Shares Issued
SharesIssued
277200 shares
CY2020Q2 us-gaap Stock Issued1
StockIssued1
268942 usd
CY2020Q3 f10q0922 Stock Issued During Period Shares Acquisition
StockIssuedDuringPeriodSharesAcquisition
1745000585 shares
CY2020Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
174500 usd
CY2020Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
595162 shares
CY2020Q3 f10q0922 Common Stock For Services Value
CommonStockForServicesValue
595162 usd
CY2018Q3 f10q0922 Agreement To Purchase Percentage
AgreementToPurchasePercentage
0.75 pure
CY2019Q2 f10q0922 Acquisition And Exchange Agreement Description
AcquisitionAndExchangeAgreementDescription
the Company executed an Acquisition and Exchange Agreement with Lalit Kumar Verma and Manickam Mahalingam, who together control 100% of the common shares of ABT Auto Investments Ltd., a private English company. Pursuant to the Agreement, Messrs. Verma and Mahalingam were to exchange 96,001 shares, representing 100% of the common shares of ABT Auto Investments Ltd for a total of 3,530,000,000 new issue treasury shares issued by the Company, representing 95% ownership of the Company. On June 20, 2019, the Company executed a Mutual Rescission and Release Agreement, mutually rescinding the Acquisition and Exchange Agreement with Fortress Ventures LLC represented by Lalit Kumar Verma and with ABT Investments India Pvt Ltd represented by Manickam Mahalingam. The Mutual Rescission and Release agreement executed and became effective as of June 20, 2019. As a consequence of its execution and the rescinding of the Share Exchange and Acquisition Agreement, the Company will not issue the 3,530,000,000 shares of common stock.

Files In Submission

Name View Source Status
0001477932-23-001166-index-headers.html Edgar Link pending
0001477932-23-001166-index.html Edgar Link pending
0001477932-23-001166.txt Edgar Link pending
0001477932-23-001166-xbrl.zip Edgar Link pending
f10q0922-20221231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
token_10q.htm Edgar Link pending
token_ex311.htm Edgar Link pending
token_ex312.htm Edgar Link pending
token_ex321.htm Edgar Link pending
f10q0922-20221231_def.xml Edgar Link unprocessable
f10q0922-20221231_cal.xml Edgar Link unprocessable
f10q0922-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0922-20221231_lab.xml Edgar Link unprocessable
token_10q_htm.xml Edgar Link completed